Extendryl PSE Interactions
There are 351 drugs known to interact with Extendryl PSE (methscopolamine / pseudoephedrine), along with 23 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 18 are major, 312 are moderate, and 21 are minor.
- View all 351 medications that may interact with Extendryl PSE
- View Extendryl PSE alcohol/food interactions (3)
- View Extendryl PSE disease interactions (23)
Most frequently checked interactions
View interaction reports for Extendryl PSE (methscopolamine / pseudoephedrine) and the medicines listed below.
- Allegra (fexofenadine)
- Allegra ODT (fexofenadine)
- Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
- Ativan (lorazepam)
- Ceftin (cefuroxime)
- clomipramine
- diazepam
- fluvoxamine
- pseudoephedrine
- Ritalin (methylphenidate)
- Xanax (alprazolam)
Extendryl PSE alcohol/food interactions
There are 3 alcohol/food interactions with Extendryl PSE (methscopolamine / pseudoephedrine).
Extendryl PSE disease interactions
There are 23 disease interactions with Extendryl PSE (methscopolamine / pseudoephedrine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiovascular disease
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Extendryl PSE (methscopolamine / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.